Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foretinib in Recurrent or Metastatic SCCHN
NCT00725764Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of foretinib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by GSK. Started Aug 2007; status: completed.
02
Drugs
foretinib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00725764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00725764.